Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Atherosclerotic Cardiovascular Disease (ASCVD)
In brief
The purpose of the study CTQJ230A12304, is to evaluate the efficacy, safety, and tolerability of pelacarsen (TQJ230) compared to placebo in participants with ASCVD who have elevated lipoprotein(a) (Lp(a)), and who are on background inclisiran treatment for elevated low-density lipoprotein cholesterol (LDL-C).
Key facts
- Study ID
- NCT06813911
- Run by
- Novartis Pharmaceuticals
- People needed
- 340
- Starts
- 2025-04-30
- Expected to finish
- 2028-02-29
- Last updated by the study team
- 2026-08-07
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Intermountain Medical Center — Murray, Utah, United States (enrolling)
- Novartis Investigative Site — Beijing, China (enrolling)
- Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina, United States (enrolling)
- Northwest Houston Clinical Research PLLC — Tomball, Texas, United States (enrolling)
- Novartis Investigative Site — Jining, Shandong, China (enrolling)
- Novartis Investigative Site — Xian, Shanxi, China (enrolling)
- Overlook Medical Center — Summit, New Jersey, United States (enrolling)
- Baptist Health South — Miami, Florida, United States (enrolling)
- PharmaTex Research LLC — Amarillo, Texas, United States (enrolling)
- Kelsey Seybold Research Foundation — Houston, Texas, United States (enrolling)
- Virginia Heart — Falls Church, Virginia, United States (enrolling)
- SEC Clinical Research — Pensacola, Florida, United States (enrolling)
- Peace River Cardiovascular Center — Port Charlotte, Florida, United States (enrolling)
- University Of South Florida — Tampa, Florida, United States (enrolling)
- FC Site Partners Miami — Winter Park, Florida, United States (enrolling)
- Advocate Lutheran General Childrens Hospital — Park Ridge, Illinois, United States (enrolling)
- American Health Network Research Dept — Muncie, Indiana, United States (enrolling)
- American Health Network Research Dept — Muncie, Indiana, United States (enrolling)
- Novartis Investigative Site — Tullahoma, Tennessee, United States (enrolling)
- Omega Clinical Research — Metairie, Louisiana, United States (enrolling)
- Flourish Research Bowie — Bowie, Maryland, United States (enrolling)
- Anderson Medical Research — Ft. Washington, Maryland, United States (enrolling)
- Ocala Cardiovascular Research — Ocala, Florida, United States (enrolling)
- Jacksonville Center for Clinical — Jacksonville, Florida, United States (enrolling)
- Novartis Investigative Site — Shanghai, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.